South China Pharmaceutical

Guangdong South China Pharmaceutical Group Co., Ltd. is a large-scale pharmaceutical enterprise based in Dongguan, China, specializing in the research, development, and manufacturing of chemical drugs and Traditional Chinese Medicine (TCM). The company is a major manufacturer of cardiovascular treatments, most notably its flagship Compound Danshen Tablets (Fufang Danshen Pian), and a wide range of anti-infective, anti-inflammatory, and respiratory medications. As a subsidiary of the state-owned Guangdong Rising Holdings Group, it operates extensive GMP-certified facilities and is a key supplier of essential medicines like tetracycline and dexamethasone in the Chinese market. The company also engages in the production of active pharmaceutical ingredients (APIs) and veterinary products, maintaining a strong domestic and international distribution network through its marketing arm in Shenzhen.